Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON41926
NL-OMON41926
Completed
Not Applicable

on-invasive prenatal analysis of pregnancy-course and -outcome by genome-wide RNA sequencing - Presymptomatic RNA Profiling in Pregnancy

Vrije Universiteit Medisch Centrum0 sites2,000 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPresymptomatic RNA profiling in pregnancy10026908

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Presymptomatic RNA profiling in pregnancy
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
2000
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age 18 years or older at enrollment,
  • •Clinically confirmed pregnancy,
  • •Gestational age between 9\-14 weeks,
  • •Pregnancy records accessible and available for data collection exam,
  • •Able to provide consent for participation using language appropriate forms.

Exclusion Criteria

  • •Invasive prenatal procedure (amniocentesis or CVS) performed within 2 weeks prior to enrollment,
  • •Twin pregnancy,
  • •Vanishing twin.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
on-invasive prenatal diagnosis with PAP-assay; detection of cell free fetal DNA in maternal blood.birth defectgenetic defect10083624
NL-OMON30308eids Universitair Medisch Centrum50
Active, not recruiting
Not Applicable
Prenacel Pregnant: Development and evaluation of a communication strategy to improve quality of antenatal carePrenatal Education, Birthing Centers, Perinatal Care, Prenatal care.I02.233.332.500.500N02.278.080E02.760.703E02.760.786
RBR-54zf73Faculdade de Medicina de Ribeirão Preto
Withdrawn
Not Applicable
Advanced prenatal screening in the first trimester of pregnancy: ADAM12 and PP13 as new screening markers for aneuploidy and adverse pregnancy outcome.Down syndromeTrisomy 211001399510010273
NL-OMON31468Vrije Universiteit Medisch Centrum20,000
Recruiting
Not Applicable
on invasive prenatal testing (NIPT) of fetal genetic disorders in maternal bloodgenetic disorders10083624
NL-OMON50448Medisch Universitair Ziekenhuis Maastricht400
Completed
Not Applicable
Effect of prenatal fetal surveillance on neonatal outcomes in diabetic pregnant patients
IRCT20200127046278N1Tehran University of Medical Sciences110